Latest filing published 01 Dec 2023 for NORTHWEST BIOTHERAPEUTICS INC, €114k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -83.8%Entry US$8.25 · Close at T+365 US$1.34
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Navid Malik: trading record in brief
All filings by Navid Malik on record concern Northwest Biotherapeutics Inc. Over a trading history stretching from 17 December 2013 to 17 November 2023, the count stands at 4 filings.
In open-market terms, that means 1 purchase worth €7 on one side and 3 sales worth €432k on the other. On balance, insiders were net sellers of €432k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2023 to date brings no purchases and 3 sales.
On 1 December 2023 came the latest disclosure, an open-market sale for €114k in Northwest Biotherapeutics Inc. The most recent open-market purchase was published on 30 April 2015, 4,210 days ago. Typically, a trade is published a median of 15 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Navid Malik
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 150,000 shares@ US$0.82326.3% of flowCommon StockSEC:0001104659-23-122940:1
- 295,000 shares@ US$0.81951.5% of flowCommon StockSEC:0001104659-23-122940:2
- 125,000 shares@ US$0.835100.0% of flowCommon StockSEC:0001104659-23-122940:0
- 10,000 shares@ US$0.001Common Stock, par value $0.001SEC:0001144204-15-026511:0Canonical exit: 17 Mar 2014 (T+90)
4 of 4 declarations